Literature DB >> 1080073

Optimal conditions for the growth of malignant human and animal cell populations in immunosuppressed mice.

E J Stanbredge, L R Boulger, C R Franks, J A Garrett, D E Reeson, D Bishop, F T Perkins.   

Abstract

Immunosuppressed mice have been used to support the growth of xenogeneic human and animal malignant cell populations. The optimal conditions for tumor growth are neonatal thymectomy coupled with antithymocyte serum or thymectomy, followed by whole-body irradiation and bone marrow reconstitution. When mice are inoculated with a mixture of normal and malignant cells, the malignant cells have a selective advantage. No such selectivity is found when the mixed populations are grown in vitro. Human tumors may also be grown in immunosuppressed mice. These tumors retain the organization of the original tumor in the human host. The advantages of this system to cancer researchers are discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1080073

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

1.  Rates of aggregation, loss of anchorage dependence, and tumorigenicity of cultured cells.

Authors:  T C Wright; T E Ukena; R Campbell; M J Karnovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1977-01       Impact factor: 11.205

2.  Analysis of malignancy in human cells: malignant and transformed phenotypes are under separate genetic control.

Authors:  E J Stanbridge; J Wilkinson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

3.  Anchorage-independent growth of normal human fibroblasts.

Authors:  D M Peehl; E J Stanbridge
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

4.  Growth of acute myeloid leukaemia as discrete subcutaneous tumours in immune-deprived mice.

Authors:  C R Franks; D Bishop; F R Balkwill; R T Oliver; W G Spector
Journal:  Br J Cancer       Date:  1977-05       Impact factor: 7.640

5.  Human breast-cancer xenografts in immune-suppressed mice.

Authors:  M J Bailey; J C Gazet; M J Peckham
Journal:  Br J Cancer       Date:  1980-10       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.